Newsfeeds - Spark Newswire

1 minute read

Wedbush Initiates Coverage On Theseus Pharmaceuticals with Outperform Rating, Announces Price Target of $24

Today, 9:00 PM

Wedbush analyst David Nierengarten initiates coverage on Theseus Pharmaceuticals (NASDAQ:THRX) with a Outperform rating and announces Price Target of $24.

THRX

1 minute read

SVB Leerink Initiates Coverage On Theseus Pharmaceuticals with Outperform Rating, Announces Price Target of $28

By Benzinga Newsdesk

Today, 9:00 PM

SVB Leerink analyst Andrew Berens initiates coverage on Theseus Pharmaceuticals (NASDAQ:THRX) with a Outperform rating and announces Price Target of $28.

THRX

1 minute read

Jefferies Initiates Coverage On Theseus Pharmaceuticals with Buy Rating, Announces Price Target of $23

By Benzinga Newsdesk

Today, 9:00 PM

Jefferies analyst Maury Raycroft initiates coverage on Theseus Pharmaceuticals (NASDAQ:THRX) with a Buy rating and announces Price Target of $23.

THRX

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 9:00 PM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

2 minute read

3 Stocks Insiders Are Buying

By Lisa Levin

Today, 9:00 PM

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

4 minute read

45 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:00 PM

Gainers Camber Energy, Inc.. (NYSE: CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking.

AEHR